1. Home
  2. MREO vs UPXI Comparison

MREO vs UPXI Comparison

Compare MREO & UPXI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Mereo BioPharma Group plc

MREO

Mereo BioPharma Group plc

HOLD

Current Price

$0.33

Market Cap

52.5M

Sector

Health Care

ML Signal

HOLD

Logo Upexi Inc.

UPXI

Upexi Inc.

HOLD

Current Price

$1.20

Market Cap

77.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MREO
UPXI
Founded
2015
2018
Country
United Kingdom
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Medicinal Chemicals and Botanical Products
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
52.5M
77.0M
IPO Year
2017
2021

Fundamental Metrics

Financial Performance
Metric
MREO
UPXI
Price
$0.33
$1.20
Analyst Decision
Buy
Buy
Analyst Count
5
1
Target Price
$1.50
$2.00
AVG Volume (30 Days)
1.4M
4.3M
Earning Date
05-12-2026
05-15-2026
Dividend Yield
N/A
N/A
EPS Growth
16.67
92.49
EPS
N/A
0.76
Revenue
$500,000.00
$15,811,345.00
Revenue This Year
$6,000.20
$118.99
Revenue Next Year
$34.71
N/A
P/E Ratio
N/A
$1.50
Revenue Growth
N/A
N/A
52 Week Low
$0.20
$0.54
52 Week High
$2.94
$22.53

Technical Indicators

Market Signals
Indicator
MREO
UPXI
Relative Strength Index (RSI) 40.25 58.78
Support Level $0.32 $0.91
Resistance Level $0.42 $1.28
Average True Range (ATR) 0.02 0.09
MACD 0.01 0.02
Stochastic Oscillator 29.29 84.26

Price Performance

Historical Comparison
MREO
UPXI

About MREO Mereo BioPharma Group plc

Mereo BioPharma Group PLC is a United Kingdom (U.K.) based biopharmaceutical company focused on the development of therapeutics for rare diseases. The company has developed a portfolio of late-stage clinical product candidates, and its two rare disease product candidates are setrusumab for the treatment of osteogenesis imperfecta (OI) and alvelestat, mainly for the treatment of severe alpha-1 antitrypsin deficiency-associated lung disease (AATD-LD).

About UPXI Upexi Inc.

Upexi Inc specializes in the development, manufacturing, and distribution of consumer products with diversification into the cryptocurrency space via Solana. Geographically, the company generates the majority of its revenue from the United States.

Share on Social Networks: